LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$693M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$529M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
$381M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
$278M |
| 5 |
Apple
AAPL
|
$276M |
Top Sells
Sector Composition
| 1 | Technology | 8.27% |
| 2 | Financials | 3.61% |
| 3 | Consumer Discretionary | 2.98% |
| 4 | Healthcare | 2.45% |
| 5 | Industrials | 2.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4876
Anixa Biosciences
ANIX
$95.7M
| $99.6K | ﹤0.01% |
42,937
+11,633
| +37% | +$27K |
|
|
ADAP
4877
Adaptimmune Therapeutics
ADAP
$10.9M
| $98.8K | ﹤0.01% |
183,479
+94,623
| +106% | +$51K |
|
4878
Village Farms International
VFF
$301M
| $97.2K | ﹤0.01% |
126,090
+6,926
| +6% | +$5.34K |
|
4879
Cabaletta Bio
CABA
$155M
| $96.2K | ﹤0.01% |
42,386
+5,716
| +16% | +$13K |
|
|
CXE
4880
MFS High Income Municipal Trust
CXE
$113M
| $95.5K | ﹤0.01% |
25,953
-7,613
| -23% | -$28K |
|
4881
Bumble
BMBL
$697M
| $94.6K | ﹤0.01% |
11,620
-2,863
| -20% | -$23.3K |
|
4882
Quad
QUAD
$334M
| $94.1K | ﹤0.01% |
13,500
| – | – |
|
4883
Candel Therapeutics
CADL
$274M
| $92.9K | ﹤0.01% |
+10,703
| New | +$92.9K |
|
4884
CI&T Inc
CINT
$700M
| $92.9K | ﹤0.01% |
15,301
-299
| -2% | -$1.82K |
|
4885
Arcos Dorados Holdings
ARCO
$1.47B
| $92.1K | ﹤0.01% |
12,652
-707
| -5% | -$5.15K |
|
4886
D-Wave Quantum Inc. Warrants, each whole warrant exercisable for 1.4541326 shares of Common Stock at an exercise price of $11.50
QBTS.WS
$3.22B
| $91.7K | ﹤0.01% |
+23,500
| New | +$91.7K |
|
4887
Sasol
SSL
$4.51B
| $91.2K | ﹤0.01% |
20,009
-2,661
| -12% | -$12.1K |
|
4888
DarioHealth
DRIO
$23M
| $91.2K | ﹤0.01% |
5,800
-2,608
| -31% | -$41K |
|
|
MTA
4889
Metalla Royalty & Streaming
MTA
$518M
| $89.9K | ﹤0.01% |
35,804
-7,149
| -17% | -$17.9K |
|
4890
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $89.4K | ﹤0.01% |
64,765
-29,321
| -31% | -$40.5K |
|
4891
INmune Bio
INMB
$51.8M
| $89.1K | ﹤0.01% |
19,072
+4,730
| +33% | +$22.1K |
|
4892
Heron Therapeutics
HRTX
$201M
| $88.9K | ﹤0.01% |
58,098
-7,559
| -12% | -$11.6K |
|
4893
AirSculpt Technologies
AIRS
$367M
| $88.7K | ﹤0.01% |
17,097
| – | – |
|
4894
Ultralife
ULBI
$119M
| $88.5K | ﹤0.01% |
11,879
+584
| +5% | +$4.35K |
|
4895
CommScope
COMM
$3.55B
| $86.5K | ﹤0.01% |
16,601
-38,900
| -70% | -$203K |
|
|
AUTL
4896
Autolus Therapeutics
AUTL
$389M
| $86.3K | ﹤0.01% |
36,725
+850
| +2% | +$2K |
|
4897
LivePerson
LPSN
$89.9M
| $86K | ﹤0.01% |
56,571
+33,021
| +140% | +$50.2K |
|
4898
TETRA Technologies
TTI
$625M
| $85.2K | ﹤0.01% |
23,807
-596,175
| -96% | -$2.13M |
|
4899
Motorcar Parts of America
MPAA
$281M
| $83.7K | ﹤0.01% |
11,010
+1,000
| +10% | +$7.6K |
|
4900
Nuvation Bio
NUVB
$1.33B
| $83.4K | ﹤0.01% |
31,348
+6,673
| +27% | +$17.8K |
|